Donifoxate Febuxostat 40Mg 30 Tablets
A medication is used to reduce the production of uric acid in the body. It is utilized to manage conditions associated with excessive uric acid levels.
Indications:
- Treatment of chronic gout.
- Management of hyperuricemia in patients with gout.
- Prevention of uric acid buildup in patients undergoing chemotherapy.
Main Active Ingredients:
- Febuxostat.
Precautions:
- Use with caution in patients with liver or kidney impairment.
- Monitor liver function tests and serum uric acid levels regularly.
- May increase the risk of cardiovascular events.
- Not recommended for patients with ischemic heart disease or congestive heart failure.
Side Effects:
- Liver function abnormalities.
- Nausea and vomiting.
- Diarrhea.
- Rash.
- Cardiovascular events .
Drug-Drug Interactions:
- May interact with:
- Azathioprine.
- Mercaptopurine.
- Monitor theophylline if co-administered.
- Warfarin.
Indications:
- Treatment of chronic gout.
- Management of hyperuricemia in patients with gout.
- Prevention of uric acid buildup in patients undergoing chemotherapy.
Main Active Ingredients:
- Febuxostat.
Precautions:
- Use with caution in patients with liver or kidney impairment.
- Monitor liver function tests and serum uric acid levels regularly.
- May increase the risk of cardiovascular events.
- Not recommended for patients with ischemic heart disease or congestive heart failure.
Side Effects:
- Liver function abnormalities.
- Nausea and vomiting.
- Diarrhea.
- Rash.
- Cardiovascular events .
Drug-Drug Interactions:
- May interact with:
- Azathioprine.
- Mercaptopurine.
- Monitor theophylline if co-administered.
- Warfarin.
$2.74
Original: $9.12
-70%Donifoxate Febuxostat 40Mg 30 Tablets—
$9.12
$2.74Product Information
Product Information
Shipping & Returns
Shipping & Returns
Description
A medication is used to reduce the production of uric acid in the body. It is utilized to manage conditions associated with excessive uric acid levels.
Indications:
- Treatment of chronic gout.
- Management of hyperuricemia in patients with gout.
- Prevention of uric acid buildup in patients undergoing chemotherapy.
Main Active Ingredients:
- Febuxostat.
Precautions:
- Use with caution in patients with liver or kidney impairment.
- Monitor liver function tests and serum uric acid levels regularly.
- May increase the risk of cardiovascular events.
- Not recommended for patients with ischemic heart disease or congestive heart failure.
Side Effects:
- Liver function abnormalities.
- Nausea and vomiting.
- Diarrhea.
- Rash.
- Cardiovascular events .
Drug-Drug Interactions:
- May interact with:
- Azathioprine.
- Mercaptopurine.
- Monitor theophylline if co-administered.
- Warfarin.
Indications:
- Treatment of chronic gout.
- Management of hyperuricemia in patients with gout.
- Prevention of uric acid buildup in patients undergoing chemotherapy.
Main Active Ingredients:
- Febuxostat.
Precautions:
- Use with caution in patients with liver or kidney impairment.
- Monitor liver function tests and serum uric acid levels regularly.
- May increase the risk of cardiovascular events.
- Not recommended for patients with ischemic heart disease or congestive heart failure.
Side Effects:
- Liver function abnormalities.
- Nausea and vomiting.
- Diarrhea.
- Rash.
- Cardiovascular events .
Drug-Drug Interactions:
- May interact with:
- Azathioprine.
- Mercaptopurine.
- Monitor theophylline if co-administered.
- Warfarin.
